Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis

BACKGROUND: Pneumonia and pneumococcal disease cause a large disease burden in resource-constrained settings. We pursue an extended cost-effectiveness analysis (ECEA) of two fully publicly financed interventions in Ethiopia: pneumococcal vaccination for newborns and pneumonia treatment for under-fiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Kjell Arne, Memirie, Solomon Tessema, Pecenka, Clint, Jamison, Dean T., Verguet, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674114/
https://www.ncbi.nlm.nih.gov/pubmed/26650078
http://dx.doi.org/10.1371/journal.pone.0142691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674114/
https://www.ncbi.nlm.nih.gov/pubmed/26650078
http://dx.doi.org/10.1371/journal.pone.0142691

Ejemplares similares